Tag: Blood Glucose Monitors
Access to Modern Technologies, Insulin Affects HbA1c Levels in Pediatric Type 1 Diabetes
Lower mean HbA1c levels seen for centers with full reimbursement for CGM, CSII, glucometers, and insulin
FDA Clears OTC Glucose Monitoring System for Weight Management
System integrates glucose biosensor with an AI-driven platform to show how food, activity, stress, sleep affect the body in real time
2009 to 2023 Saw Increase in Use of Technology, Glycemic Control in Type...
Prevalence of glycemic control and use of diabetes technology lowest in Hispanic, non-Hispanic Black, Medicaid-insured
Disparities Seen in Continuous Glucose Monitor Rx by Language Preference
Among adult patients with type 2 diabetes, CGM prescriptions less likely for those with non-English language preference
Low-Glucose Alerts Beneficial for Insulin-Treated Drivers With Diabetes
Low-glucose alerts improve time below range for drivers with T1D and reduce incidence of low glucose for all insulin-treated drivers
Continuous Glucose Monitors Overestimate Glycemic Responses
Variation in CGM bias by postprandial test, with glycemic index for commercial fruit smoothie higher with CGM versus capillary sampling
Study Explores Effect of Hybrid Closed-Loop Therapy on Diabetic Complications
Hybrid closed-loop insulin delivery does not affect rate of severe hypoglycemia and increases rate of ketoacidosis
Wrong Smartphone Settings Can Lead to Missed Alerts From Linked Diabetes Devices
Hardware and software changes, updates, and configurations can result in undelivered critical safety alerts
Continuous Glucose Monitoring Can Predict Microvascular Complications in Type 1 Diabetes
Time-in-range computed from virtual CGM data predicts retinopathy, neuropathy similarly to glycated hemoglobin data
FDA Expands Approval of Omnipod 5 Insulin Delivery System to Include Patients With Type...
Omnipod 5 works in concert with a continuous glucose monitor to manage blood glucose with no daily injections and no finger pricks
